Flurbiprofen sodium
- Level
- Commodity
- Parent
- 51384500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384524This classification denotes a cyclooxygenase inhibitor and carbonic anhydrase inhibitor with the molecular formula C15H12FO2.Na.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z5B97MU9K4, chemically known as 4-biphenylacetic acid, 2-fluoro-alpha-methyl- but more generally known as flurbiprofen sodium, which bears US NIH Compound Identifier 3394. European Medicines Agency schedules Flurbiprofen sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02240MIG. Most nations, for tariff and trade purposes, schedule flurbiprofen sodium under HS 29163900 and SITC 51379. As of Q4 2014, FLURBIPROFEN SODIUM remains US FDA's Preferred Term for this commodity. Flurbiprofen sodium bears US NLM identifiers UMLS ID C0304658 and NCI Concept Code C47997. SMILES: CC(C1CCC(C(C1)F)C2CCCCC2)C(=O)[O-].O.O.[NA+].
Same parent
Under 51384500 · 34Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.